Examkin

Soru

Zorluk: OrtaPreventive Care and Immunizations

A 12-month-old girl is brought to the clinic for a routine well-child visit. She was diagnosed with perinatal human immunodeficiency virus (HIV) infection. Over the past 6 months, she has been treated for an episode of *Pneumocystis jirovecii* pneumonia and recurrent oral candidiasis. Her current medications include a combination antiretroviral therapy regimen and trimethoprim-sulfamethoxazole. Her mother expresses concern because the infant is pulling to a stand and cruising along furniture but is not yet walking independently without support. The infant babbles and consistently says "mama" and "dada." Vital signs are within normal limits for age. Physical examination is unremarkable. Laboratory studies obtained 3 days ago show a CD4 T-lymphocyte percentage of 12%. The patient has received all previously scheduled age-appropriate immunizations. Which of the following is the most appropriate next step in management regarding this patient's preventive care today?

  1. Administer scheduled inactivated vaccines and withhold live-attenuated vaccinesCevap
  2. B
    Administer all scheduled vaccines, including live-attenuated and inactivated vaccines
  3. C
    Administer live-attenuated vaccines and delay inactivated vaccines
  4. D
    Withhold all immunizations until the CD4 T-lymphocyte percentage is greater than 15%
  5. E
    Withhold all immunizations and refer for urgent neurodevelopmental evaluation

Cevap

Administer scheduled inactivated vaccines and withhold live-attenuated vaccines
The correct course of action is to administer the scheduled inactivated vaccines and withhold the live-attenuated vaccines. At 12 months of age, children routinely receive both inactivated vaccines (such as the pneumococcal conjugate and hepatitis A vaccines) and live-attenuated vaccines (such as the measles-mumps-rubella [MMR] and varicella vaccines). However, this patient has HIV with a CD4 T-lymphocyte percentage of 12%. According to immunization guidelines, a CD4 percentage less than 15% represents severe immunosuppression. In this state, live-attenuated vaccines are absolutely contraindicated because they can cause widespread, life-threatening vaccine-strain infections. Inactivated vaccines, on the other hand, cannot replicate and are completely safe. They should be administered on schedule to provide crucial protection against other infections.

Adım Adım Çözüm

1
Assess the patient's age and routinely indicated vaccines.
At 12 months of age, children are typically scheduled to receive a mix of inactivated vaccines (e.g., PCV, HepA, Hib) and live-attenuated vaccines (MMR, Varicella).
Establishing the baseline well-child recommendations helps determine what interventions are currently due.
2
Evaluate the patient's immune status and comorbidities.
The patient has HIV with a CD4 T-lymphocyte percentage of 12% and a history of opportunistic infections.
Vaccination safety, particularly for live vaccines, relies heavily on the patient's level of immunocompetence.
3
Apply immunization guidelines for HIV-infected children.
A CD4 percentage of less than 15% in a child of any age indicates severe immunosuppression. Live vaccines must be withheld. Inactivated vaccines should be given as scheduled.
Live-attenuated vaccines pose a severe risk of disseminated infection in severely immunocompromised hosts. Inactivated vaccines pose no infectious risk.
4
Evaluate the mother's developmental concerns.
Pulling to stand, cruising, and saying 'mama'/'dada' are normal gross motor and language milestones for a 12-month-old.
To ensure there are no other contraindications or urgent conditions that take precedence over routine preventive care.

Anahtar Kavram

In pediatric patients with HIV and severe immunosuppression (CD4 percentage < 15%), live-attenuated vaccines (e.g., MMR, Varicella) are contraindicated, but inactivated vaccines should be administered according to the routine schedule.
Bu soruyu puanla

Konular

Preventive Care and Immunizations

Bu konudan daha fazla soru